T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer

T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase 2 clinical study of MT027, its internally developed, ...

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that ...

Measured Evaluation of Renovation Effects in Performance-Improving Renovations of Existing Detached Houses

This study compares and analyzes the effects of improving the performance of existing detached houses through renovation, ...
Indiatimes

HDFC Medium Term Fund Direct-Growth

Get the best filtered funds based on our pre-defined screeners. 1. HDFC Medium Term Fund - Direct Plan is Open-ended Medium Term Debt scheme which belongs to HDFC Mutual Fund House. 2. The fund was ...